Medical experts, patient advocacy groups and high-profile Australians are partnering with GSK Australia to help raise community awareness about invasive meningococcal disease (IMD).
\nThis educational initiative is focused on the signs, symptoms and risk factors of this rare, but potentially devastating disease. The initiative encourages people to speak to their healthcare professional for more information about meningococcal disease, given the total cases reported to end September 20221 have already exceed last year’s total cases for the full year (86 cases as of end September 2022, 74 cases in 2021).
\nThe prevalence of IMD declined during 2020-2021 as lockdowns restricted movement and travel1. But as Australians travel and become more mobile, IMD circulation in the community is increasing, thereby posing a risk to children and adolescents, who are most at risk of the disease.
\nInfectious diseases paediatrician, Professor Robert Booy, says it is critical for families to know signs and symptoms of invasive meningococcal disease and that an awareness campaign like this is being rolled out at a perfect time.
\n“Given we are experiencing an increased level of population movements, I encourage everyone, especially parents of young children, to be talking to their doctor about invasive meningococcal disease. It can strike anyone, and we already see an increase in meningococcal disease cases locally and in other countries, like UK, where the number of cases are nearing pre-pandemic levels,” says Professor Booy.
\n“Time is of the essence when it comes to minimising the potentially lethal consequences of IMD. We can reduce its impact by educating people about the signs and symptoms to look out for. Confusing the symptoms with a common cold for example, can put the life of loved ones at risk.”
\nIMD is a rare bacterial infection which can progress rapidly. Early signs and symptoms may be difficult to diagnose as they can easily be mistaken for a common cold, for example high fever or lethargy.2 Most people who contract meningococcal disease survive, but it’s important that it is diagnosed and treated quickly.5 Up to one in ten of those infected may die, and up to one in five survivors may develop serious long-term complications, including brain damage, deafness or loss of limbs.3
\nMeningococcal disease can occur at any age, however, babies (under 2 year of age) and adolescents (15–19 years of age) are most vulnerable to the disease, which is spread by secretions from the nose and throat of a person who is carrying the bacteria. This generally requires close and prolonged contact with a person carrying the bacteria.4
\nGSK Australia has partnered with Australian medical experts, patient advocates and ambassadors to help spread the word on digital media and a dedicated website (https://knowmeningococcal.com.au/).
\nThe campaign ambassador Felicity Harley, an author, host of Body + Soul's 'Healthy-ish’ podcasts and wife of an AFL legend Tom Harley, has her own family experience of IMD, as her son Hugo contracted the disease at the age of five weeks old.
\n“I still vividly remember driving my listless and incredibly ill baby to the hospital and not knowing if he would live. Acting quickly on the first symptoms may have saved his life,” said Ms Harley.
\n“I cannot imagine where Hugo and our whole family would be now if those signs were missed. I urge all parents to keep meningococcal disease signs and symptoms front of mind.”
\nKaren Quick, CEO of Meningitis Centre Australia, says she is pleased to see increasing attention to community education around IMD.
\n“For over 30 years Meningitis Centre Australia has been working hard to make information about IMD easily available to help parents understand the risk their children may face,” said Ms Quick. “Now more than ever with the increase in IMD cases, parents need to know the signs and symptoms of this disease, so they can act immediately, save lives and avoid potential long-term disability. This information is easily accessible on our website.”
\n“Meningococcal is a devastating disease for Australians and their families. If contracted, it can cause significant impact on the whole community. It is wonderful to see so many people joining forces to raise awareness, educate the community and encourage people to talk to their healthcare professional.”
\nFor more information about meningococcal, speak to your healthcare professional and visit https://knowmeningococcal.com.au/
","useGreyBackground":false,"fullWidth":false},{"type":"rich-text","text":"About Invasive Meningococcal Disease (IMD)
\nIMD is a rare bacterial infection caused by a bacteria called Neisseria meningitidis.2 There are 13 known serogroups (strains) that can cause the disease. The most common serogroups globally are A, B, C, W, and Y.6 In Australia, strains B, W and Y cause the majority of the meningococcal disease cases.6
\nWhile most will survive and recover, this rare but devastating infection can progress rapidly and lead to serious disability (up to 1 in 5 who survive the disease may suffer long-term complications, including brain damage, deafness or loss of limb) or death (up to in 1 in 10 infected may die) within 24 hours. 2,3,5
\nWhile meningococcal disease can occur at any age, infants and young children (< 2 years of age), followed by adolescents between 15-19 years of age, are most at risk.4
\nEarly symptoms of meningococcal disease, such as high fever and lethargy, may be difficult to recognise and can easily be mistaken for a common cold. Other symptoms of meningococcal disease amongst babies, young children and adolescents may include vomiting, pale blotchy skin, cold hands and feet, and sensitivity to light. Babies may also have a high-pitched moaning cry and/or a bulging fontanelle. The distinctive purple meningococcal rash is an advanced symptoms of blood infection, which may or may not occur.7
\nAbout GSK
\nGSK is a science-led global healthcare company. For further information please visit www.gsk.com/about-us.
\nGSK enquiries
\nMedia enquiries:
\nAnastasiia Nazarenko +61 435 977 559
\n(Palin Communications)
\nAngela Hill +61 466 514 894
\nReferences
\n
The Know Meningococcal campaign is sponsored by GSK Australia.
GSK, Melbourne, VIC NP-AU-MNX-PRSR-220001 Date of GSK Approval: October 2022
","useGreyBackground":false,"fullWidth":false}]},"id":7109,"docCheckLogout":null,"pageType":"pressReleasePage","languageCode":"en-AU","theme":"light","breadcrumb":{"ariaLabel":"Breadcrumb","links":[{"text":"Home","href":"/en-au/","openInNewWindowText":null},{"text":"Media","href":"/en-au/media/","openInNewWindowText":null},{"text":"Press releases","href":"/en-au/media/press-releases/","openInNewWindowText":null},{"text":"Invasive meningococcal disease cases already surpassing 2021 total figures","href":"/en-au/media/press-releases/invasive-meningococcal-disease-cases-already-surpassing-2021-total-figures/","openInNewWindowText":null}]},"pageName":"Invasive meningococcal disease cases already surpassing 2021 total figures","topNav":{"homeLink":{"text":"GSK Homepage","href":"/en-au/","openInNewWindowText":null},"topBar":{"currentLocation":{"isGlobal":false,"text":"Australia (EN)"},"languageSelector":{"currentLanguage":null,"currentLanguageMobile":null,"selectableLanguages":[]},"darkModeSwitch":{"text":"Dark Mode","tooltipText":"Switch to dark mode to head towards a more sustainable world together. More info
"},"globalSiteLink":{"text":"Global","href":"https://www.gsk.com","openInNewWindowText":null},"locationSelector":{"text":"Location selector","href":"/en-au/locations/","openInNewWindowText":null},"healthCareLink":{"text":"Healthcare professionals","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"contactUs":{"text":"Contact us","href":"/en-au/contact-us/","openInNewWindowText":null},"search":"Search","backToMain":"Back to main","menu":"Menu","closeMenu":"Close menu","animationsToggleModel":{"enable":true,"activeText":"Pause video","inactiveText":"Play video"}},"nodes":[{"tooltip":null,"hasBorderRight":false,"title":"Company ","url":"/en-au/company/","nodes":[{"title":"Purpose, strategy and culture","url":"/en-au/company/purpose-strategy-and-culture/","nodes":[],"isActive":false},{"title":"At a glance ","url":"/en-au/company/at-a-glance/","nodes":[],"isActive":false},{"title":"Australian leadership team","url":"/en-au/company/australian-leadership-team/","nodes":[],"isActive":false},{"title":"Policies","url":"/en-au/company/policies/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Purpose and strategy","image":{"src":"/media/uzcle0ma/gskh_3_2022_comspc_22_hess-2-1.jpg?width=329&height=185&format=webp&quality=100&v=1dbe5b9a7a7e3f0&hmac=84049620a3bc758f887d4f32cd0fd2a8262f9dcbc5cd6dfbfefdd695da788c25","alt":"laughing coworkers in an office setting","darkModeSrc":"/media/uzcle0ma/gskh_3_2022_comspc_22_hess-2-1.jpg?width=329&height=185&format=webp&quality=50&v=1dbe5b9a7a7e3f0&hmac=db3422d205be21640f6103daec954369bb08de976519259843210322506b798d"},"link":{"text":"Featured section","href":"/en-au/company/purpose-strategy-and-culture/","openInNewWindowText":null}},{"text":"At a glance","image":{"src":"/media/mpbpjmth/aq5a7428_2-1.jpg?width=329&height=185&format=webp&quality=100&v=1dbe5b9b0a75b70&hmac=46357150b18a88aaf0c0219de1c3ebe05343e5729e796c6de807f431f70c0bf3","alt":"smiling coworkers in gsk house","darkModeSrc":"/media/mpbpjmth/aq5a7428_2-1.jpg?width=329&height=185&format=webp&quality=50&v=1dbe5b9b0a75b70&hmac=264e01786518191c80654a353d6f96269fa319d962caa9d4156dcef0c0835ee9"},"link":{"text":"Featured section","href":"/en-au/company/at-a-glance/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Innovation","url":"/en-au/innovation/","nodes":[{"title":"Therapeutic areas","url":"/en-au/innovation/therapeutic-areas/","nodes":[],"isActive":false},{"title":"Clinical trials at GSK","url":"/en-au/innovation/clinical-trials-at-gsk/","nodes":[],"isActive":false},{"title":"GSK Award for Research Excellence","url":"/en-au/innovation/gsk-award-for-research-excellence/","nodes":[{"title":"2026 GSK ARE Nominations","url":"/en-au/innovation/gsk-award-for-research-excellence/2026-gsk-are-nominations/","nodes":[],"isActive":false},{"title":"Previous winners","url":"/en-au/innovation/gsk-award-for-research-excellence/previous-winners/","nodes":[],"isActive":false},{"title":"Alumni members","url":"/en-au/innovation/gsk-award-for-research-excellence/alumni-members/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Global Behind the science magazine","image":{"src":"/media/hxxhs40x/gsk_rsv_6k_rgb-2-1.jpg?width=329&height=185&format=webp&quality=100&v=1dbe5b9a7008060&hmac=d6c1ed1eadc1b4e060e1e8136c869a1678136c2b88435062eaec73203e897e69","alt":"RSV science image","darkModeSrc":"/media/hxxhs40x/gsk_rsv_6k_rgb-2-1.jpg?width=329&height=185&format=webp&quality=50&v=1dbe5b9a7008060&hmac=59139c5580e8ad81078a1c82481a93df48d79bed854f8eb4d295bffca37fba2e"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/behind-the-science-magazine/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Therapeutic areas","image":{"src":"/media/5sqn0ebv/gsk_rsv_updated_close_still_6k_cmyk.jpg?width=329&height=185&format=webp&quality=100&v=1dbe5b9b14bb1c0&hmac=3eb21ace7d115b27509bf849934f13779eb232add170b2ae8704cb37599967cc","alt":"RSV close up","darkModeSrc":"/media/5sqn0ebv/gsk_rsv_updated_close_still_6k_cmyk.jpg?width=329&height=185&format=webp&quality=50&v=1dbe5b9b14bb1c0&hmac=4966fcaa17109992ee812654088c508442abcde504d68dd0aacc6777a48b2325"},"link":{"text":"Featured section","href":"/en-au/innovation/therapeutic-areas/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Products","url":"/en-au/products/","nodes":[{"title":"Product list","url":"/en-au/products/product-list/","nodes":[],"isActive":false},{"title":"Report a possible side effect","url":"/en-au/products/report-a-possible-side-effect/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"GSK Pro ","image":{"src":"/media/divnrvoc/gsk_03_2022_port_10_eagle_light_2-2.jpg?width=329&height=185&format=webp&quality=100&v=1dbe5b9ae0eaf30&hmac=5eda24bfd4315c63b9209cdc82ebd4fdfdb913ac1007fb9444f64bd9212cd3a1","alt":"smiling woman","darkModeSrc":"/media/divnrvoc/gsk_03_2022_port_10_eagle_light_2-2.jpg?width=329&height=185&format=webp&quality=50&v=1dbe5b9ae0eaf30&hmac=6f93d5d703b7e37f4afcdaad90aae916debc5d85db4aa61aa6ed6e240f1350bc"},"link":{"text":"Featured website","href":"https://gskpro.com/en-au/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Innovation","image":{"src":"/media/tial52vw/gsk_shingles_6k_rgb.jpg?width=329&height=185&format=webp&quality=100&v=1dbe5b9a837c7e0&hmac=51f40e2ee2f242d629e9ad32d3186aad93c34b0768815840bf4010db9a7612e2","alt":"shingles science image","darkModeSrc":"/media/tial52vw/gsk_shingles_6k_rgb.jpg?width=329&height=185&format=webp&quality=50&v=1dbe5b9a837c7e0&hmac=61202d0aba712d8cb7e06a888641aae1fd9fa9d148f055457ec462d9f9102648"},"link":{"text":"Spotlight on","href":"/en-au/innovation/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Responsibility","url":"/en-au/responsibility/","nodes":[{"title":"Inclusion","url":"/en-au/responsibility/inclusion/","nodes":[{"title":"Reconciliation in Australia","url":"/en-au/responsibility/inclusion/reconciliation-in-australia/","nodes":[],"isActive":false}],"isActive":false},{"title":"Ethical standards","url":"/en-au/responsibility/ethical-standards/","nodes":[{"title":"Engaging with healthcare professionals","url":"/en-au/responsibility/ethical-standards/engaging-with-healthcare-professionals/","nodes":[],"isActive":false},{"title":"Engaging with Australian patient advocacy groups","url":"/en-au/responsibility/ethical-standards/engaging-with-australian-patient-advocacy-groups/","nodes":[],"isActive":false}],"isActive":false},{"title":"Our policy advocacy","url":"/en-au/responsibility/our-policy-advocacy/","nodes":[{"title":"Pulling back the curtain","url":"/en-au/responsibility/our-policy-advocacy/pulling-back-the-curtain/","nodes":[],"isActive":false},{"title":"Vaccine access reports","url":"/en-au/responsibility/our-policy-advocacy/vaccine-access-reports/","nodes":[{"title":"Prevention: A Productivity Superpower","url":"/en-au/responsibility/our-policy-advocacy/vaccine-access-reports/prevention-a-productivity-superpower/","nodes":[],"isActive":false},{"title":"The value of vaccines","url":"/en-au/responsibility/our-policy-advocacy/vaccine-access-reports/the-value-of-vaccines/","nodes":[],"isActive":false},{"title":"Risk to resilience: a roadmap to vaccine access for older Australians","url":"/en-au/responsibility/our-policy-advocacy/vaccine-access-reports/risk-to-resilience-a-roadmap-to-vaccine-access-for-older-australians/","nodes":[],"isActive":false}],"isActive":false},{"title":"Prevention: A Productivity Superpower","url":"/en-au/responsibility/our-policy-advocacy/prevention-a-productivity-superpower/","nodes":[],"isActive":false}],"isActive":false},{"title":"Save The Children","url":"/en-au/responsibility/save-the-children/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Inclusion","image":{"src":"/media/gsyjwwlm/gsk_03_2022_port_8_eagle_light-1-2-1.jpg?width=329&height=185&format=webp&quality=100&v=1dbe5b9a71ae630&hmac=e5d8e84204842aee9363dbc7aa308420e27c5121451ab15624b7976025bb1732","alt":"man and woman laughing","darkModeSrc":"/media/gsyjwwlm/gsk_03_2022_port_8_eagle_light-1-2-1.jpg?width=329&height=185&format=webp&quality=50&v=1dbe5b9a71ae630&hmac=c3378a95b906a88c0386d0de23c474f39cacd2689b33e56a4c48cd9b077128fe"},"link":{"text":"Featured section","href":"/en-au/responsibility/inclusion/","openInNewWindowText":null}},{"text":"Reconciliation in Australia","image":{"src":"/media/otxbnm5o/rap-artwork.png?width=329&height=185&format=webp&quality=100&v=1dbe5b9b0ffdbb0&hmac=b08825adbfcf72ce24a33cedb542a29dca2d7d82569749f266f2eb656323d153","alt":"colorful dna illustration","darkModeSrc":"/media/otxbnm5o/rap-artwork.png?width=329&height=185&format=webp&quality=50&v=1dbe5b9b0ffdbb0&hmac=8751ac5a2d508298816edae7cb5401d0cc73bd0a70cfbb8ce84125988c73ea85"},"link":{"text":"Featured section","href":"/en-au/responsibility/inclusion/reconciliation-in-australia/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Media","url":"/en-au/media/","nodes":[{"title":"Press releases","url":"/en-au/media/press-releases/","nodes":[],"isActive":true},{"title":"Media contacts","url":"/en-au/media/media-contacts/","nodes":[],"isActive":false},{"title":"Supply updates","url":"/en-au/media/supply-updates/","nodes":[],"isActive":false}],"isActive":true,"promos":[{"text":"Press releases","image":{"src":"/media/fnhhsxgk/gskh_3_2022_comspc_36_hess2-1.jpeg?width=329&height=185&format=webp&quality=100&v=1dbe5b9a73c02c0&hmac=20ba505507446f3a73a9ea97644caf2ed83d5e7e3c18fa1b00d8825fba10ccff","alt":"man walking in gsk house","darkModeSrc":"/media/fnhhsxgk/gskh_3_2022_comspc_36_hess2-1.jpeg?width=329&height=185&format=webp&quality=50&v=1dbe5b9a73c02c0&hmac=de3b6fbae94fcc8a07413d6964053fb7fb4f7a897e0ac5c7cc82e0d632c2b56c"},"link":{"text":"Featured section","href":"/en-au/media/press-releases/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Careers","url":"/en-au/careers/","nodes":[{"title":"Life at GSK","url":"/en-au/careers/life-at-gsk/","nodes":[],"isActive":false},{"title":"Sales professionals","url":"/en-au/careers/sales-professionals/","nodes":[],"isActive":false},{"title":"Industry Based Learning programme","url":"/en-au/careers/industry-based-learning-programme/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Inclusion ","image":{"src":"/media/gsyjwwlm/gsk_03_2022_port_8_eagle_light-1-2-1.jpg?width=329&height=185&format=webp&quality=100&v=1dbe5b9a71ae630&hmac=e5d8e84204842aee9363dbc7aa308420e27c5121451ab15624b7976025bb1732","alt":"man and woman laughing","darkModeSrc":"/media/gsyjwwlm/gsk_03_2022_port_8_eagle_light-1-2-1.jpg?width=329&height=185&format=webp&quality=50&v=1dbe5b9a71ae630&hmac=c3378a95b906a88c0386d0de23c474f39cacd2689b33e56a4c48cd9b077128fe"},"link":{"text":"Spotlight on","href":"/en-au/responsibility/inclusion/","openInNewWindowText":null}},{"text":"Search careers","image":{"src":"/media/gwil1ks4/aq5a6732_2-1.jpg?width=329&height=185&format=webp&quality=100&v=1dbe5b9b132d290&hmac=6b66cb04e76dde13165a471ec73702963c56615d8aeb37d5d0913133b3e4ef9e","alt":"two women talking","darkModeSrc":"/media/gwil1ks4/aq5a6732_2-1.jpg?width=329&height=185&format=webp&quality=50&v=1dbe5b9b132d290&hmac=50969d095a9fe57ab38f1b3486edd6666bf0fc072770d2d74336a99eeeaf0bcd"},"link":{"text":"Featured Section","href":"/en-au/careers/","openInNewWindowText":null}}]}],"skipToContent":null,"skipToSearch":null,"typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=1702","searchFieldPlaceholderText":"Enter a search term...","searchPage":"/en-au/search/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"This website is intended for visitors seeking information on GSK Australia’s business. Our other market sites can be reached by visiting our market selector.
\n© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. 4/436 Johnston St, Abbotsford VIC 3067.
","modernSlaveryStatement":null,"sections":{"socialMedia":{"columnTitle":"Follow us on:","socialMediaItems":[{"globalLink":{"text":null,"href":"https://www.facebook.com/pages/GSK-Australia/236736887274951","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on Facebook","customIcon":null,"showPopupMenu":false,"type":"Facebook"},{"globalLink":{"text":null,"href":"https://twitter.com/GSK_AU","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on X","customIcon":null,"showPopupMenu":false,"type":"X"},{"globalLink":{"text":null,"href":"https://www.youtube.com/GSK","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on Youtube","customIcon":null,"showPopupMenu":false,"type":"Youtube"},{"globalLink":{"text":null,"href":"https://www.linkedin.com/company/glaxosmithkline/","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on LinkedIn","customIcon":null,"showPopupMenu":false,"type":"LinkedIn"},{"globalLink":{"text":null,"href":"https://www.instagram.com/gsk/","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on Instagram","customIcon":null,"showPopupMenu":false,"type":"Instagram"}]},"columns":[{"columnTitle":"GSK Websites","links":[{"text":"Global website","href":"https://www.gsk.com/en-gb/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Market website selector","href":"/en-au/locations/","openInNewWindowText":null},{"text":"Global Behind the Science magazine","href":"https://www.gsk.com/en-gb/behind-the-science-magazine/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSK Pro for healthcare professionals","href":"https://gskpro.com/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"ViiV Healthcare","href":"https://viivhealthcare.com/en-au/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Supplier website","href":"https://supplier.gsk.com/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Quick links","links":[{"text":"Company","href":"/en-au/company/","openInNewWindowText":null},{"text":"Innovation","href":"/en-au/innovation/","openInNewWindowText":null},{"text":"Our products","href":"/en-au/products/","openInNewWindowText":null},{"text":"Responsibility","href":"/en-au/responsibility/","openInNewWindowText":null},{"text":"Media","href":"/en-au/media/","openInNewWindowText":null},{"text":"Careers","href":"/en-au/careers/","openInNewWindowText":null}]},{"columnTitle":"Get in touch ","links":[{"text":"Contact us","href":"/en-au/contact-us/","openInNewWindowText":null},{"text":"Report a possible side effect","href":"/en-au/products/report-a-possible-side-effect/","openInNewWindowText":null},{"text":"GSK speak up","href":"https://gsk.i-sight.com/landing-page/","target":"_blank","openInNewWindowText":"Opens in a new window"}]}]},"bottomLinks":[{"text":"Accessibility","href":"/en-au/accessibility/","target":"_parent","openInNewWindowText":"Opens in a new window"},{"text":"Digital sustainability","href":"/en-au/digital-sustainability/","openInNewWindowText":null},{"text":"Terms of use","href":"/en-au/terms-of-use/","target":"_parent","openInNewWindowText":"Opens in a new window"},{"text":"Cookie policy","href":"/en-au/cookie-policy/","target":"_parent","openInNewWindowText":"Opens in a new window"},{"text":"Privacy notice","href":"https://privacy.gsk.com/en-au/privacy-notice/general/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Sitemap","href":"/en-au/sitemap/","openInNewWindowText":null}],"continueToLink":null,"legalApprovalText":""},"sharing":{"description":"GSK Australia helps raise community awareness of Invasive Meningococcal Disease (IMD).","og":[{"property":"og:title","content":"Invasive meningococcal disease cases already surpassing 2021 total figures"},{"property":"og:description","content":"GSK Australia helps raise community awareness of Invasive Meningococcal Disease (IMD)."},{"property":"og:image","content":"https://au.gsk.com/media/fk4nvvko/flp-header-1.jpg?rxy=0.55333333333333334,0.38666666666666666&width=600&format=webp&quality=100&v=1dbe5bab2b86bb0&hmac=014504a918950e9d371c22d6b9057e5839c9606e1bec7290a4c34fae8cf4ffbd"},{"property":"og:url","content":"https://au.gsk.com/en-au/media/press-releases/invasive-meningococcal-disease-cases-already-surpassing-2021-total-figures/"}],"twitter":[{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:site","content":"@gsk"},{"name":"twitter:title","content":"Invasive meningococcal disease cases already surpassing 2021 total figures"},{"name":"twitter:description","content":"GSK Australia helps raise community awareness of Invasive Meningococcal Disease (IMD)."},{"name":"twitter:image","content":"https://au.gsk.com/media/fk4nvvko/flp-header-1.jpg?rxy=0.55333333333333334,0.38666666666666666&width=600&format=webp&quality=100&v=1dbe5bab2b86bb0&hmac=014504a918950e9d371c22d6b9057e5839c9606e1bec7290a4c34fae8cf4ffbd"},{"name":"twitter:url","content":"https://au.gsk.com/en-au/media/press-releases/invasive-meningococcal-disease-cases-already-surpassing-2021-total-figures"}]},"stickyShare":null,"exitSitePreferences":{"popupEnabled":true,"title":"You are leaving our website","texts":"The information you are about to be referred to may not comply with the local regulatory requirements. Further information relevant to the local environment is available from the company or via the Product Information.
","continueText":"Continue","cancelText":"Cancel","exclusionUrls":["https://www.facebook.com/GSK","http://doingmoreintheus.gsk.com/en-us/map-regions/","https://www.gsk.com","https://innovation.gsk.com/","https://www.gskgrants.com","https://www.gskforyou.com/","http://fortherecord.payments.us.gsk.com","https://www.gsk-clinicalstudyregister.com/","https://www.contactus.gsk.com/callback/index.html","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","http://www.msds-gsk.com/","http://www.gskgrants.com/","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsk.com/media/2941/human-rights-statement-policy.pdf","http://www.gsk.com/media/280848/human-rights-statement-policy.pdf","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","http://twitter.com/GSK","http://www.flickr.com/photos/glaxosmithkline","http://www.linkedin.com/company/glaxosmithkline","https://www.instagram.com/gsk/ ","http://www.gsk-clinicalstudyregister.com/","http://www.gskforyou.com/","https://www.gskforyou.com/prescription-resource-assistance/immunology-respiratory/","https://www.contactus.gsk.com/callback.html","https://access.gsk.com/password/","https://access.gsk.com/selfservice/static/login.jsp?TYPE=33554433&REALMOID=06-c7edf5ec-5585-100d-83b1-84797f88fc89&GUID=&SMAUTHREASON=0&METHOD=GET&SMAGENTNAME=-SM-90R5K5a0NsTyKRhPyTIn3A3B5ovKkqcehflGRUrUNusjZdRaPY%2bWUozEFizs1bMg&TARGET=-SM-https%3a%2f%2fuksah%2egsk%2ecom%2fswh_uk_win_ns%2fcommunications%2femployee%2femployees%2ehtm","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://ascend.cvmsolutions.com/Account/Login?client=gsk","https://twitter.com/GSK","https://www.gsk.com/media/5097/our-approach-to-responsible-business_sept-18.pdf","https://www.gsk.com/media/2538/gsk-materiality-process.pdf","https://www.gsk.com/media/4552/our-code-of-practice.pdf","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=10","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.instagram.com/gsk/","https://twitter.com/gsk","https://twitter.com/gskus","https://www.youtube.com/GSK","https://www.gsk.com/en-gb/media/image-and-video-library/","https://www.gsk.com/media/5041/rd-update-slides-hal-barron.pdf","https://gskearlytalent.avature.net/landingpage","https://www.youtube.com/channel/UChWuz9ZDceHYHXmJVJ4hF8Q","https://www.youtube.com/channel/UCN1XeWQWLVhFLHQwZl93jFQ","https://www.youtube.com/channel/UCwQyIfV4pLlsZGuN7fiZm2w","https://twitter.com/gsk_ar","https://twitter.com/GSK_Asia","https://twitter.com/gsk_conferences","https://twitter.com/gsk_au","https://twitter.com/GSK_DE","https://twitter.com/GSKCH_INDIA","https://twitter.com/GSK_IE","https://twitter.com/gsk_it","https://twitter.com/GSKScience","https://twitter.com/stiefel","https://www.gsk.com/media/4931/gsk-quick-facts.pdf","https://ie.gsk.com/ie/careers/apprenticeships/","https://gsk.i-sight.com/landing-page/","https://www.gskforyou.com/","https://jobs.gsk.com/en-us/jobs?keywords=RichmondConsumerHealthcareR%26D&page=1","https://jobs.gsk.com/en-us/jobs?page=1&location=Lincoln,%20NE,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://jobs.gsk.com/en-us/jobs?page=1&location=Carlisle,%20PA,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://jobs.gsk.com/en-us/jobs?page=1&location=East%20Durham,%20NY,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://twitter.com/GSK_AU","https://gskpro.com/en-au/","https://privacy.gsk.com/en-au/privacy-notice/general/","https://privacy.gsk.com/en-au/privacy-notice/general","https://au.gsk.com/en-au/procurement-at-gsk/","https://twitter.com/GSK_AU","https://au.gsk.com/media/479727/anoro_ellipta_cmi_au.pdf","https://www.advil.net.au/","https://www.sensodyne.com/en-au/","https://www.pronamel.com.au/","https://www.mydenturecare.com/en-au/","https://www.panadol.com/en-au/","https://www.panadol.com.au/children/children/","https://www.voltaren.com.au/","https://www.otrivin.com.au/","https://www.panadol.com/en-au/products/cold-and-flu/","https://www.centrum.net.au/","https://www.nexium24hr.com.au/","https://viivhealthcare.com/en-au/","https://au.viivexchange.com/","https://viivhealthcare.com/en-au/","https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Australia---Victoria---Abbotsford/Industry-Based-Learning-Program--Australia--2022---Expressions-of-Interest_279769","https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/New-Zealand---North-Island---Auckland/Industry-Based-Learning-Program--New-Zealand--2022---Expressions-of-Interest_279771","https://survey.gsk.com/TakeSurvey.aspx?SurveyID=l6KK3l23J#","https://twitter.com/GSK_AU","https://survey.gsk.com/TakeSurvey.aspx?SurveyID=l6KK3l23J#","https://survey.gsk.com/TakeSurvey.aspx?SurveyID=l6KK3l23J#","https://twitter.com/GSK_AU?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor","https://knowmeningococcal.com.au/","https://www.preventablediseases.com.au/travel","https://www.voltaren.com.au/","https://gskpro.com/en-au/","https://www.panadol.com/en-au/","https://www.panadol.com/en-au/children/children/","https://gskpro.com/en-au/","https://www.gsk.com/en-gb/behind-the-science-magazine/","https://www.gsk.com/en-gb/","https://viivhealthcare.com/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/infectious-diseases/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/hiv/","https://viivhealthcare.com/en-gb/","https://www.gsk.com/en-gb/company/governance/compliance/","https://www.gsk.com/en-gb/innovation/partnerships/","https://www.gsk.com/en-gb/innovation/trials/","https://www.gsk.com/en-gb/responsibility/","https://www.gsk.com/en-gb/responsibility/pricing-and-access/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/diversity-equity-and-inclusion/","https://www.gsk.com/en-gb/responsibility/environmental-sustainability/","https://www.gsk.com/en-gb/responsibility/ethical-standards/","https://www.gsk.com/en-gb/responsibility/product-governance/","https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/","https://www.gsk.com/en-gb/company/codes-standards-and-reports/","https://www.gsk.com/en-gb/company/policy-positions/","https://www.gsk-studyregister.com/en/","https://www.gsk.com/en-gb/media/press-releases/","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk.com/en-gb/company/gsk-at-a-glance/","https://www.gsk.com/en-gb/innovation/technologies/","https://www.gsk.com/en-gb/innovation/rd-locations/","https://gskpro.com/en-au/","https://www.gsk.com/en-gb/contact-us/worldwide/","https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Australia---Victoria---Abbotsford/GSK-IBL-Internship-Programme--Australia--2023---Sales---Marketing_342927-1","https://www.gsk.com/en-gb/responsibility/","https://www.gsk-studyregister.com/","https://gskpro.com","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/New-Zealand---North-Island---Auckland/GSK-IBL-Internship-Programme--New-Zealand--2023---Sales---Marketing_342930","https://www.gsk.com/en-gb/media/our-response-to-covid-19/","https://www.gsk.com/en-gb/investors/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/oncology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/immunology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/opportunity-driven/","https://www.gsk.com/en-gb/innovation/pipeline/","https://www.gsk.com/en-gb/responsibility/","https://www.gsk.com/en-gb/innovation/trials/diversity-in-clinical-trials/","https://www.gsk.com/en-gb/responsibility/charitable-partnerships/","https://supplier.gsk.com/irj/portal/public?NavigationTarget=navurl://6b2635c570145d619f22cd6903141fc3&guest_user=SUP_GUEST_EN","https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Australia---Victoria---Abbotsford/GSK-IBL-Internship-Programme--Australia--2023---Business-Operations_342924","https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/New-Zealand---North-Island---Auckland/GSK-IBL-Internship-Programme--New-Zealand--2023---Business-Operations_342931","https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Australia---Victoria---Abbotsford/GSK-IBL-Internship-Programme--Australia--2023---Medical---Clinical_342806","https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/New-Zealand---North-Island---Auckland/GSK-IBL-Internship-Programme--New-Zealand--2023---Medical---Clinical_342929","https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Australia---Victoria---Abbotsford/GSK-Graduate-Researcher-Program--Australia--2023---Expressions-of-Interest_331941-1","https://www.gsk.com/en-gb/responsibility/improving-health-globally/","https://supplier.gsk.com/irj/portal/public","https://gskpro.com/","https://us.gsk.com/en-us/responsibility/us-charitable-investments#philadelphia-stem","https://www.gsk.com/en-gb/company/board-of-directors-and-leadership-team/","https://www.facebook.com/pages/GSK-Australia/236736887274951","https://www.linkedin.com/company/glaxosmithkline/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/","https://www.gsk.com/en-gb/responsibility/ethical-standards/working-with-third-parties/","https://au.gsk.com/media/lgwadm4h/terms-of-reference-for-nomination-2026.pdf","https://au.gsk.com/media/jf3f5w5g/2025-gsk-award-for-research-excellence-nomination-form.pdf"]},"settings":{"optionalStylesheetLink":null,"themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://au.gsk.com/media/vdtbhtjo/gsk-logo-2.png?width=104&format=webp&quality=100&v=1dbe5b9b2ef4fa0&hmac=102eb3b63609a97167877a4477ecff39eabb492a001608302d23cd359ecb475b","alt":"Gsk Logo (2)","darkModeSrc":"https://au.gsk.com/media/vdtbhtjo/gsk-logo-2.png?width=104&format=webp&quality=50&v=1dbe5b9b2ef4fa0&hmac=befce838fd71bfc2a031ddf3cc5a8f8fec5e49e30ef38f96ba48278a80f8d75d"},"scripts":[{"pageLocation":"Top","text":" \n"}],"globalWebsiteLink":{"text":"Global","href":"https://www.gsk.com","openInNewWindowText":null},"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK AU"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"Back to top","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://au.gsk.com/en-au/media/press-releases/invasive-meningococcal-disease-cases-already-surpassing-2021-total-figures/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":null}